High-Intensity Cannabis Use and Adherence to Antiretroviral Therapy Among People Who Use Illicit Drugs in a Canadian Setting
Bibliographic Data
| ID | 15338121 |
|---|---|
| Authors | Gregory Slawson (University of British Columbia, corresponding author), M‐j Milloy (0000-0003-3821-6221, St. Paul's Co-educational College), Lynda G Balneaves (0000-0002-6535-2096, University of British Columbia), Lynda Balneaves, Annick Simo (St. Paul's Hospital), Silvia Guillemi (St. Paul's Hospital), Robert S Hogg (0000-0003-3463-5488, St. Paul's Hospital), Julio Montaner (0000-0002-6201-9829, St. Paul's Co-educational College), Evan Wood (0000-0001-9412-6699, St. Paul's Co-educational College), Thomas Kerr (0000-0002-0870-7153, University of British Columbia) |
| Year | 2014 |
| Volume | 19 |
| Issue | 1 |
| Pages | 120-127 |
| Publication date | 2014-07-10 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | AIDS and Behavior (JOURNAL) |
| Journal identifiers | ISSN: 1090-7165 • E-ISSN: 1573-3254 |
| Publisher | Springer Science+Business Media (PUBLISHER • DE) |
| DOI | 10.1007/s10461-014-0847-3 |
| PMID | 25012624 |
| PMCID | PMC4289662 |
| OpenAlex | W1994261721 |
| Language | EN |
| Citations received | 13 |
| References cited | 48 |
Cannabis · Cohort · Cohort study · Confidence interval · Drug · Health psychology · Odds ratio · Prospective cohort study · Psychiatry · Public health · Recreational drug use · Bipolar Disorder and Treatment · Cannabis and Cannabinoid Research · HIV/AIDS Research and Interventions · Medicine · Internal Medicine
The role of cannabis in pain management among people living with HIV who use drugs
Cannabis use and illicit opioid cessation among people who use drugs living with chronic pain
Daily and near-daily cannabis use is associated with HIV viral load suppression in people living with HIV who use cocaine
Cannabis Use, Medication Management and Adherence Among Persons Living with HIV
The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States
Substance Use, Violence, and Antiretroviral Adherence
High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada
Self-Reported Cannabis Use and HIV Viral Control among Patients with HIV Engaged in Care
Medical, therapeutic, and recreational use of cannabis among young men who have sex with men living with HIV
Disentangling Medicinal and Recreational cannabis Use Among People Living with HIV
Correlates of Using Medically-Authorized Cannabis in a Large Cohort of People Living with HIV Who Use Cannabis
Mental Health and ART Adherence in a Multisite International Study
Cannabis legalization in Canada
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up
Simulation Study of Confounder-Selection Strategies
The CES-D Scale
Marijuana as therapy for people living with HIV/Aids
Determinants of Haart discontinuation among injection drug users
Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting
Barriers to access to medical cannabis for Canadians living with HIV/Aids
Medication Compliance and Satisfaction with Treatment for HIV Disease in a Sample of African-American Crack Cocaine Smokers
Drug Use and Medication Adherence among HIV-1 Infected Individuals
Homelessness and unstable housing associated with an increased risk of HIV and STI transmission among street-involved youth
Homelessness and Adherence to Antiretroviral Therapy among a Cohort of HIV-Infected Injection Drug Users
Adherence to HIV combination therapy
| Citations per year | 1.44 |
|---|---|
| Citation span | 2017 - 2026 (10) |
| Highly cited | No |